SeaStar Medical Holding Corporation
ICU
Rank in Stocks
#30280
SeaStar Medical Holding Corporation is a medical device company dedicated to... SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
Share Price
$1.96
Last synced: 2026-11-09
Market Cap
$5.56M
Change (1 day)
4.26%
Change (1 year)
-60.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SeaStar Medical Holding Corporation (ICU)
Category
Healthcare
Operating Margin for SeaStar Medical Holding Corporation (ICU)
Operating Margin as of November 2026 TTM: -816.64%
According to SeaStar Medical Holding Corporation's latest financial reports, its current operating margin (TTM) is -816.64%. At the end of 2025 the company had an operating margin of -986.63%.
Operating Margin history for SeaStar Medical Holding Corporation from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -816.64% | -17.23% |
| 2025 | -986.63% | -92.53% |
| 2024 | -13,216.30% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.05% |
US
|
|
| -149.01% | -99.82% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 31.23% | -100.04% |
BE
|
|
| 29.35% | -100.04% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SeaStar Medical Holding Corporation's operating margin
What is SeaStar Medical Holding Corporation's operating margin?
SeaStar Medical Holding Corporation's operating margin is -816.64%, as of Nov 2026.
What was SeaStar Medical Holding Corporation's operating margin in 2025?
In 2025, SeaStar Medical Holding Corporation's operating margin was -986.63%, compared with -13,216.30% in 2024.
How has SeaStar Medical Holding Corporation's operating margin changed since 2020?
From 2020 to 2025, SeaStar Medical Holding Corporation's operating margin was highest in 2023 (0.00%) and lowest in 2024 (-13,216.30%).
How does SeaStar Medical Holding Corporation's operating margin compare with similar companies?
SeaStar Medical Holding Corporation's operating margin (-816.64%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.